News & Trends - MedTech & Diagnostics
Is the NSW healthcare investment a genuine lifeline or just political posturing?

MedTech & Diagnostics News: The New South Wales (NSW) Government has unveiled a $3 billion investment dedicated to enhancing healthcare infrastructure in greater Western Sydney, marking one of the most substantial investments in recent memory.
The highlights of this announcement include the rebuilding of Bankstown-Lidcombe Hospital on a new site, the establishment of a brand-new hospital in Rouse Hill — the first adult public hospital to be built in Western Sydney in over four decades — and investments exceeding hundreds of millions of dollars in upgrading Fairfield and Canterbury Hospitals.
This hefty investment comes on the heels of alarming data from the Bureau of Health Information (BHI), which reveals that nearly 53,000 patients sought emergency care across the Western Sydney Local Health District during the April to June quarter of 2023. Shockingly, this data exposes the agonisingly long wait times faced by patients, with a mere 42% commencing their treatment as scheduled.
Michael Bonning, President of the Australian Medical Association (NSW) and Chief Medical Officer, remarked, “The Australian Medical Association (NSW) has long stressed the need to focus on improving community access to healthcare. The residents of Western Sydney deserve the Chris Minns government’s $3 billion commitment for new and improved hospital facilities at Rouse Hill, Mt Druitt, Fairfield, Bankstown-Lidcombe, Canterbury and Blacktown. This needs to be matched with medical staffing. A hospital bed needs a well-trained team to look after you.”
NSW Premier Chris Minns asserted, “We were elected with a clear mandate to rebuild essential services and invest in our frontline workers. Our healthcare system has been under incredible pressure in recent years, exacerbated by chronic underinvestment from the former government. The thousands of people moving into these growth areas every year deserve world-class healthcare – a commitment my government will steadfastly uphold.”
Opposition Leader Mark Speakman decried some aspects of the plan as mere re-announcements of the previous government rather than innovative initiatives. Shadow Treasurer Damien Tudehope echoed these sentiments, highlighting that “what we are seeing from the government is really an endorsement of the health priorities of the previous government.”
Minister for Western Sydney Prue Car lauded the historic investment, emphasising Western Sydney’s vital role in the state’s growth and the necessity for a proportional investment in services. She stated, “After many years of false promises, this historic level of investment by the Minns Labor Government delivers what the community has been crying out for.”
However, Associate Professor Viraj Kariyawasam, Consultant Gastroenterologist and Hepatologist, stated “There is a lot more to be done. I have been part of a hospital development that delivered state-of-the-art infrastructure that was not appropriately matched with staffing and other resources. We need to get it right this time around.”
Reimagining healthcare across the entire patient journey: Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change in healthcare.
The content on Health Industry Hub is copyright protected and can only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.
Digital & Innovation

Liverpool Hospital partners with Microsoft in cardiology care
Digital & Innovation: Liverpool Hospital and tech giant Microsoft have joined forces in a collaboration aimed at enhancing the way […]
MoreNews & Trends - MedTech & Diagnostics

Sydney cancer centre welcomes new medical technology ahead of grand opening
MedTech & Diagnostics News: A $52 million integrated cancer treatment facility in Campbelltown, located in south-western Sydney, is swiftly advancing […]
MoreNews & Trends - Pharmaceuticals

Largest pharmacy retailer ASX debut via wholesaler takeover sparks industry concerns
Pharma News: Australia’s largest pharmacy retailer is gearing up for a significant move as it eyes a listing on the […]
MoreNews & Trends - Pharmaceuticals

Eli Lilly’s rheumatoid arthritis medicine to slow progression of type 1 diabetes, say Aussie researchers
Pharma News: Australian researchers have shown that a commonly prescribed rheumatoid arthritis medicine can stop the progression of type 1 […]
More